These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 9364987

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Studies on the different modes of action of the anticoagulant protease inhibitors DX-9065a and Argatroban. I. Effects on thrombin generation.
    Nagashima H.
    J Biol Chem; 2002 Dec 27; 277(52):50439-44. PubMed ID: 12496240
    [Abstract] [Full Text] [Related]

  • 5. Anticoagulant potential of synthetic and recombinant inhibitors of factor Xa and thrombin in vitro.
    Hauptmann J, Kaiser B.
    Blood Coagul Fibrinolysis; 1993 Aug 27; 4(4):577-82. PubMed ID: 8218854
    [Abstract] [Full Text] [Related]

  • 6. Synthetic selective inhibitors of coagulation factor Xa strongly inhibit thrombin generation without affecting initial thrombin forming time necessary for platelet activation in hemostasis.
    Ieko M, Tarumi T, Takeda M, Naito S, Nakabayashi T, Koike T.
    J Thromb Haemost; 2004 Apr 27; 2(4):612-8. PubMed ID: 15102016
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of extrinsic and intrinsic thrombin generation by a novel synthetic thrombin inhibitor (Ro 46-6240), recombinant hirudin and heparin in human plasma.
    Gast A, Tschopp TB.
    Blood Coagul Fibrinolysis; 1995 Sep 27; 6(6):553-60. PubMed ID: 7578898
    [Abstract] [Full Text] [Related]

  • 8. Fibrin-targeted direct factor Xa inhibition: construction and characterization of a recombinant factor Xa inhibitor composed of an anti-fibrin single-chain antibody and tick anticoagulant peptide.
    Hagemeyer CE, Tomic I, Jaminet P, Weirich U, Bassler N, Schwarz M, Runge MS, Bode C, Peter K.
    Thromb Haemost; 2004 Jul 27; 92(1):47-53. PubMed ID: 15213844
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative studies on the anticoagulant and protease generation inhibitory actions of newly developed site-directed thrombin inhibitory drugs. Efegatran, argatroban, hirulog, and hirudin.
    Callas DD, Hoppensteadt D, Fareed J.
    Semin Thromb Hemost; 1995 Jul 27; 21(2):177-83. PubMed ID: 7660140
    [Abstract] [Full Text] [Related]

  • 11. Influence of recombinant hirudin and unfractionated heparin on thrombin and factor Xa generation in extrinsic and intrinsic activated systems.
    Kaiser B, Fareed J, Hoppensteadt D, Birdsong B, Walenga JM, Markwardt F.
    Thromb Res; 1992 Jan 15; 65(2):157-64. PubMed ID: 1579892
    [Abstract] [Full Text] [Related]

  • 12. Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin.
    Wong PC, Jiang X.
    Thromb Haemost; 2010 Aug 15; 104(2):302-10. PubMed ID: 20589316
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the effect of fondaparinux and enoxaparin on thrombin generation during in-vitro clotting of whole blood and platelet-rich plasma.
    Gerotziafas GT, Depasse F, Chakroun T, Van Dreden P, Samama MM, Elalamy I.
    Blood Coagul Fibrinolysis; 2004 Mar 15; 15(2):149-56. PubMed ID: 15091002
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nonpeptide factor Xa inhibitors: I. Studies with SF303 and SK549, a new class of potent antithrombotics.
    Wong PC, Quan ML, Crain EJ, Watson CA, Wexler RR, Knabb RM.
    J Pharmacol Exp Ther; 2000 Jan 15; 292(1):351-7. PubMed ID: 10604970
    [Abstract] [Full Text] [Related]

  • 16. Dibasic (amidinoaryl)propanoic acid derivatives as novel blood coagulation factor Xa inhibitors.
    Nagahara T, Yokoyama Y, Inamura K, Katakura S, Komoriya S, Yamaguchi H, Hara T, Iwamoto M.
    J Med Chem; 1994 Apr 15; 37(8):1200-7. PubMed ID: 8164262
    [Abstract] [Full Text] [Related]

  • 17. Inactivation of factor Xa by the synthetic inhibitor DX-9065a causes strong anticoagulant and antiplatelet actions in human blood.
    Kaiser B, Jeske W, Walenga JM, Fareed J.
    Blood Coagul Fibrinolysis; 1999 Dec 15; 10(8):495-501. PubMed ID: 10636461
    [Abstract] [Full Text] [Related]

  • 18. DX-9065a inhibition of factor Xa and the prothrombinase complex: mechanism of inhibition and comparison with therapeutic heparins.
    Rezaie AR.
    Thromb Haemost; 2003 Jan 15; 89(1):112-21. PubMed ID: 12540961
    [Abstract] [Full Text] [Related]

  • 19. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
    Bhunia SS, Roy KK, Saxena AK.
    J Chem Inf Model; 2011 Aug 22; 51(8):1966-85. PubMed ID: 21761917
    [Abstract] [Full Text] [Related]

  • 20. Species differences in anticoagulant and anti-Xa activity of DX-9065a, a highly selective factor Xa inhibitor.
    Hara T, Yokoyama A, Morishima Y, Kunitada S.
    Thromb Res; 1995 Oct 01; 80(1):99-104. PubMed ID: 8578544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.